These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Regulations of phage therapy across the world. Yang Q; Le S; Zhu T; Wu N Front Microbiol; 2023; 14():1250848. PubMed ID: 37869667 [TBL] [Abstract][Full Text] [Related]
26. TradReg 2013: regulation of herbal and traditional medicinal products--European and global strategies--international symposium. Cranz H; Anquez-Traxler C J Ethnopharmacol; 2014 Dec; 158 Pt B():495-7. PubMed ID: 25281419 [TBL] [Abstract][Full Text] [Related]
27. The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards. Shi J; Chen X; Hu H; Ung COL Cytotherapy; 2024 Aug; 26(8):954-966. PubMed ID: 38739075 [TBL] [Abstract][Full Text] [Related]
29. Progress review of the European Paediatric Regulatory Framework after six years of implementation. Mentzer D Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178 [TBL] [Abstract][Full Text] [Related]
30. Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products. Bretaudeau L; Tremblais K; Aubrit F; Meichenin M; Arnaud I Front Microbiol; 2020; 11():1161. PubMed ID: 32582101 [TBL] [Abstract][Full Text] [Related]
31. [Review of the development in European Legislation on the harmonisation of the laws for medicinal products]. Lehmann B Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):713-21. PubMed ID: 18584107 [TBL] [Abstract][Full Text] [Related]
32. Regulatory aspects of stability testing in Europe. Matthews BR Drug Dev Ind Pharm; 1999 Jul; 25(7):831-56. PubMed ID: 10459489 [TBL] [Abstract][Full Text] [Related]
33. Regulatory guidelines for biosimilars in Malaysia. Abas A Biologicals; 2011 Sep; 39(5):339-42. PubMed ID: 21784655 [TBL] [Abstract][Full Text] [Related]
34. Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries. Coppens DGM; Hoekman J; De Bruin ML; Slaper-Cortenbach ICM; Leufkens HGM; Meij P; Gardarsdottir H Cytotherapy; 2020 Oct; 22(10):592-600. PubMed ID: 32563611 [TBL] [Abstract][Full Text] [Related]
35. Regulatory pathways for vaccines for developing countries. Milstien J; Belgharbi L Bull World Health Organ; 2004 Feb; 82(2):128-33. PubMed ID: 15042235 [TBL] [Abstract][Full Text] [Related]
36. A Thorough Synthesis of Phage Therapy Unit Activity in Poland-Its History, Milestones and International Recognition. Żaczek M; Górski A; Weber-Dąbrowska B; Letkiewicz S; Fortuna W; Rogóż P; Pasternak E; Międzybrodzki R Viruses; 2022 May; 14(6):. PubMed ID: 35746642 [TBL] [Abstract][Full Text] [Related]
37. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation. Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547 [TBL] [Abstract][Full Text] [Related]
38. European regulatory conundrum of phage therapy. Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471 [TBL] [Abstract][Full Text] [Related]
39. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union. Kroes BH J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408 [TBL] [Abstract][Full Text] [Related]
40. Mechanics of the Food and Drug Administration's Form 1571: investigational new drug application. Novack G Retina; 2005 Dec; 25(8 Suppl):S96-S97. PubMed ID: 16374362 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]